-
Something wrong with this record ?
The role of autophagic cell death and apoptosis in irinotecan-treated p53 null colon cancer cells
J. Stanislav, J. Mls, M. Červinka, E. Rudolf,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Apoptosis drug effects physiology MeSH
- Autophagy drug effects physiology MeSH
- HT29 Cells MeSH
- Antineoplastic Agents, Phytogenic pharmacology therapeutic use MeSH
- HCT116 Cells MeSH
- Camptothecin analogs & derivatives pharmacology therapeutic use MeSH
- Humans MeSH
- Cell Line, Tumor MeSH
- Tumor Suppressor Protein p53 deficiency genetics MeSH
- Colonic Neoplasms drug therapy genetics metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The roles of autophagic cell death and apoptosis induced by topoisomerase inhibitor irinotecan in colon cancer cells with deleted p53 were investigated during 48 h. We report that irinotecan-dependent cytotoxicity and proapoptotic activity were reduced in the present model while autophagy levels significantly increased. Upon p53 transfection, cell demise rates increased, with cells bearing the features of apoptosis and autophagic cell death. The subsequent studies into mechanisms of cell death process revealed the important role of Bax in mediating mitochondrial and lysosomal leakage which might serve as leading signals for both apoptosis and autophagic cell death. These results suggest that different modes of cell death in p53 null colon cancer cells treated with cytostatics (irinotecan) may be activated simultaneously. Moreover, their interactions possibly occur at several stages and aren't mutually exclusive. This might thus lead to a potential synergism with interesting therapeutic ramifications.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14051247
- 003
- CZ-PrNML
- 005
- 20140408110904.0
- 007
- ta
- 008
- 140401s2013 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2174/1871520611313050015 $2 doi
- 035 __
- $a (PubMed)22721392
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Stanislav, John
- 245 14
- $a The role of autophagic cell death and apoptosis in irinotecan-treated p53 null colon cancer cells / $c J. Stanislav, J. Mls, M. Červinka, E. Rudolf,
- 520 9_
- $a The roles of autophagic cell death and apoptosis induced by topoisomerase inhibitor irinotecan in colon cancer cells with deleted p53 were investigated during 48 h. We report that irinotecan-dependent cytotoxicity and proapoptotic activity were reduced in the present model while autophagy levels significantly increased. Upon p53 transfection, cell demise rates increased, with cells bearing the features of apoptosis and autophagic cell death. The subsequent studies into mechanisms of cell death process revealed the important role of Bax in mediating mitochondrial and lysosomal leakage which might serve as leading signals for both apoptosis and autophagic cell death. These results suggest that different modes of cell death in p53 null colon cancer cells treated with cytostatics (irinotecan) may be activated simultaneously. Moreover, their interactions possibly occur at several stages and aren't mutually exclusive. This might thus lead to a potential synergism with interesting therapeutic ramifications.
- 650 _2
- $a fytogenní protinádorové látky $x farmakologie $x terapeutické užití $7 D000972
- 650 _2
- $a apoptóza $x účinky léků $x fyziologie $7 D017209
- 650 _2
- $a autofagie $x účinky léků $x fyziologie $7 D001343
- 650 _2
- $a kamptothecin $x analogy a deriváty $x farmakologie $x terapeutické užití $7 D002166
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a nádory tračníku $x farmakoterapie $x genetika $x metabolismus $7 D003110
- 650 _2
- $a HCT116 buňky $7 D045325
- 650 _2
- $a buňky HT-29 $7 D019073
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádorový supresorový protein p53 $x nedostatek $x genetika $7 D016159
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mls, Jan $u -
- 700 1_
- $a Červinka, Miroslav $u -
- 700 1_
- $a Rudolf, Emil $u -
- 773 0_
- $w MED00172590 $t Anti-cancer agents in medicinal chemistry $x 1875-5992 $g Roč. 13, č. 5 (2013), s. 811-20
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22721392 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140401 $b ABA008
- 991 __
- $a 20140408110952 $b ABA008
- 999 __
- $a ok $b bmc $g 1018383 $s 849827
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 13 $c 5 $d 811-20 $i 1875-5992 $m Anti-cancer agents in medicinal chemistry $n Anticancer Agents Med Chem $x MED00172590
- LZP __
- $a Pubmed-20140401